Nona Biosciences Expands Discovery-to-Clinical Capabilities
Nona Biosciences has strengthened its integrated discovery-to-clinical framework by expanding proprietary platform technologies and enhancing preclinical and early clinical development capabilities, including CMC development, toxicology and clinical operations.
CMC Development | 24/12/2025 | By News Bureau | 100
Sai Life Sciences Set to Double Process R&D Capacity with New Facility in Hyderabad
The upcoming Process R&D Block at Sai Life Sciences will cover 100,000 sq. ft. across five floors, featuring 140 process chemistry fume hoods, an integrated satellite analytical lab, and dedicated peptide and oligo labs, supported by a 25,000 sq. ft. central analytical facility.
CMC Development | 28/10/2025 | By Dineshwori | 250
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy